# ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

> **NCT03082222** · — · COMPLETED · sponsor: **Eisai GmbH** · enrollment: 246 (actual)

## Conditions studied

- Focal Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03082222
- **Lead sponsor:** Eisai GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-10-29
- **Final completion:** 2018-10-29
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2019-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082222, "ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03082222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*